National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials (PDQ®)
Patient Version   Health Professional Version
First Published: 9/4/2008  
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma
Pilot Study of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia-Related Side-Effects in Women Undergoing Surgery for Breast Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Registry Information

Alternate Title

Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedSupportive careActive18 and overNCICHNMC-08029
08029, NCT00748267

Objectives

  1. To test the feasibility of hypnosis as a pre-operative intervention for the reduction of surgical- and anesthesia-related symptoms in women undergoing lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection for locally recurrent breast cancer.
  2. To identify the physical symptoms (i.e., pain, nausea, and vomiting) and psychological symptoms (i.e., anxiety and distress) of patients undergoing hypnosis.
  3. To determine the length of stay in the Post Anesthesia Care Unit of patients undergoing adjunct hypnosis.
  4. To describe patient satisfaction with the hypnosis experience.
  5. To determine the effect size and calculate the sample needed for a randomized clinical trial using the results of this study.

Entry Criteria

Disease Characteristics:

  • Diagnosis of breast cancer


  • Scheduled for breast surgery (i.e., lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection) with Dr. Garbaroglio


  • Hormone receptor status not specified


Prior/Concurrent Therapy:

  • See Disease Characteristics
  • No concurrent reconstruction surgery

Patient Characteristics:

  • Menopausal status not specified
  • Able to speak and read English
  • Able to follow instruction
  • No uncontrolled major comorbid mental conditions (i.e., thought disorders)
  • No uncontrolled major physical conditions (i.e., untreated congestive heart failure)

Expected Enrollment

25

Outcomes

Primary Outcome(s)

Pain as measured by the Condensed Memorial Symptom Assessment Scale (CMSAS)-Modified at baseline (pre-intervention) and prior to discharge from the Post Anesthesia Care Unit
Nausea as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit
Vomiting as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit
Generalized distress as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit
Anxiety as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit
Surgical and anesthesia time
Recovery time
Medications
Levels of consciousness
Standard clinical measures of levels of anesthesia
Significant surgical events
Patient satisfaction

Outline

Patients undergo a scripted hypnotic intervention over 15 minutes within 1 hour prior to their planned surgical procedure. Upon completion of the intervention, patients proceed to the Preoperative Holding Area of the Surgery and Post Anesthesia Care Unit where they receive the standard of care for lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection.

Patients undergo collection of demographic information (i.e., age; gender; ethnicity; marital/partnered status; spiritual practice; family members in the home; stress management history; experience with the continuum of imagery/hypnosis practices; perceptions of concentration abilities; and favorite aromas, colors, and scenes from nature) at the time of consent using the Demographic Survey Questionnaire. They also undergo assessment of physical and psychological symptoms (i.e., pain, nausea, vomiting, anxiety, and generalized distress) at baseline (immediately prior to hypnotic induction) and after the intervention (prior to discharge from the Post Anesthesia Care Unit).

Trial Contact Information

Trial Lead Organizations

City of Hope Comprehensive Cancer Center

Michael Lew, MD, Principal investigator
Ph: 626-359-8111; 800-826-4673

Trial Sites

U.S.A.
California
  Duarte
 City of Hope Comprehensive Cancer Center
 Kate Kravits, RN, MA
Ph: 800-826-4673

See All Trial Sites

Registry Information
Official Title Use of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia Related Side-Effects
Trial Start Date 2008-08-11
Trial Completion Date 2009-08-11 (estimated)
Registered in ClinicalTrials.gov NCT00748267
Date Submitted to PDQ 2008-08-15
Information Last Verified 2008-12-07
NCI Grant/Contract Number CA33572

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov